GNL Gut and Liver
  1. Seogsong Jeong, Yohwan Lim, Su Kyoung Lee, Hyun Wook Han. Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”. Clin Mol Hepatol 2023;29:810
    https://doi.org/10.3350/cmh.2023.0129
  2. Saemi Han, Seogsong Jeong, Joseph C. Ahn, Yoosun Cho, Seulggie Choi, Sun Jae Park, Kyae Hyung Kim, Gyeongsil Lee, Joung Sik Son, Sang Min Park. Association of post-smoking cessation changes in fasting serum glucose with changes in predicted fatty liver score. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-37194-x
  3. Seogsong Jeong, Woo-Young Shin, Yun Hwan Oh. Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1150360
  4. Seung Mi Lee, Geum Joon Cho, Won Young Wi, Errol R. Norwitz, Bo Kyung Koo, Jeesun Lee, Young Mi Jung, Soo Heon Kwak, Chan-Wook Park, Jong Kwan Jun, Sae Kyung Joo, Min-Jeong Oh, Won Kim, Joong Shin Park. Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study. Hepatol Int 2023;17:367
    https://doi.org/10.1007/s12072-022-10458-w
  5. Lei Liu, Changfa Wang, Shuwen Deng, Ting Yuan, Xiaoling Zhu, Yuling Deng, Yuexiang Qin, Yaqin Wang, Pingting Yang. Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-35733-0
  6. Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher. Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals. Gut 2023;72:1433
    https://doi.org/10.1136/gutjnl-2022-328224
  7. Xiao-Dong Zhou, Jingjing Cai, Giovanni Targher, Christopher D. Byrne, Michael D. Shapiro, Ki-Chul Sung, Virend K. Somers, C. Anwar A. Chahal, Jacob George, Li-Li Chen, Yong Zhou, Ming-Hua Zheng. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol 2022;21
    https://doi.org/10.1186/s12933-022-01697-0
  8. Jung Il Lee. Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions. Gut and Liver 2022;16:497
    https://doi.org/10.5009/gnl220276
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd